US 10980797
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
granted A61KA61K2039/505A61K31/444
Quick answer
US patent 10980797 (Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors) held by Corcept Therapeutics Incorporated expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K31/444, A61K31/4745, A61K31/57